IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 115.42% | 80.56% | 187.50% | -- | -79.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.42% | 80.38% | 187.50% | -- | -79.12% |
| Cost of Revenue | 149.46% | -7.95% | -61.13% | -71.43% | -75.97% |
| Gross Profit | 37.30% | 505.20% | 66.27% | -125.00% | -83.95% |
| SG&A Expenses | 22.63% | 41.92% | -55.08% | -72.28% | -73.54% |
| Depreciation & Amortization | -73.17% | -72.82% | -95.10% | 135.48% | -87.36% |
| Other Operating Expenses | -23.13% | -29.02% | -54.22% | -18.95% | -9.55% |
| Total Operating Expenses | -17.72% | -12.71% | -65.29% | -51.80% | -51.69% |
| Operating Income | 21.30% | 15.83% | 66.31% | 51.09% | 49.92% |
| Income Before Tax | 52.90% | 0.82% | 27.23% | -172.94% | 69.64% |
| Income Tax Expenses | -- | -- | 100.00% | -- | -2,335.00% |
| Earnings from Continuing Operations | 51.84% | 0.88% | 24.84% | -172.94% | 70.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.84% | 0.88% | 24.84% | -172.94% | 70.32% |
| EBIT | 21.30% | 15.83% | 66.31% | 51.09% | 49.92% |
| EBITDA | 18.77% | 13.18% | 61.02% | 51.60% | 41.47% |
| EPS Basic | 80.06% | -1,268.89% | 91.61% | -105.44% | 97.11% |
| Normalized Basic EPS | 52.72% | -1,275.00% | 100.64% | -105.42% | 97.04% |
| EPS Diluted | 80.06% | -1,268.89% | 91.21% | -105.49% | 97.11% |
| Normalized Diluted EPS | 52.72% | -1,275.00% | 100.64% | -105.43% | 97.04% |
| Average Basic Shares Outstanding | 141.33% | -92.74% | 795.57% | 1,244.44% | 924.96% |
| Average Diluted Shares Outstanding | 141.33% | -92.74% | 794.72% | 1,240.76% | 924.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |